ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

In Brief: Appropriations Bill Hung Up In Senate; Paul Black To Head B.U. Humphrey Center

September 21, 1979

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000